SV40 large T antigen-specific human T cell memory responses

Journal of Medical Virology

Volumn 80, Issue 8, 2008, Pages 1497-1504

  Coleman, Sharon ^a   Gibbs, Allen ^b   Butchart, Eric ^b   Mason, Malcolm D ^c   Jasani, Bharat ^c   Tabi, Zsuzsanna ^c,d  

^a VELINDRE CANCER CENTRE   (United Kingdom)

^b CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Epitope search; Polyomavirus; SV40; T cell memory

Indexed keywords

AMINO ACID; CYTOKINE; EPITOPE; HLA B7 ANTIGEN; VIRUS T ANTIGEN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGENICITY; MALE; MEMORY T LYMPHOCYTE; NONHUMAN; PLEURA MESOTHELIOMA; POLYOMA VIRUS; SIMIAN VIRUS 40; TARGET CELL;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL, TUMOR; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; MESOTHELIOMA; MOLECULAR SEQUENCE DATA; PEPTIDES; PLEURAL NEOPLASMS; SIMIAN VIRUS 40;

BK POLYOMAVIRUS; POLYOMAVIRUS; SIMIAN VIRUS 40;

EID: 46049102759     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21216     Document Type: Article

References (35)

1. Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson M, Dalianis T, Ramqvist T, Andersson B. 2007. Identification of a third human Polyomavirus. J Virol 81:4130-4136.
2. Bright R, Kimchi E, Shearer M, Kennedy R, Pass H. 2002. SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients. Cancer Immunol Immunother 50:682-690.
3. Butel JS, Lednicky JA. 1999. Cell and molecular biology of simian virus 40: Implications for human infections and disease. J Natl Cancer Inst 91:119-134.
4. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ, Levine AS, Procopio A. 1994. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9:1781-1790.
5. Carbone M, Bocchetta M, Cristaudo A, Emri S, Gazdar A, Jasani B, Lednicky J, Miele L, Mutti L, Pass H, Ramael M, Rizzo P, Testa J, Weggen S, Yeung A. 2003. SV40 and human brain tumors. Int J Cancer 106:140-142.
6. Coleman S, Clayton A, Mason MD, Jasani B, Adams M, Tabi Z. 2005. Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer. Cancer Res 65:7000-7006.
7. Cutrone R, Lednicky J, Dunn G, Rizzo P, Bocchetta M, Chumakov K, Minor P, Carbone M. 2005. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res 65:10273-10279.
8. Feng H, Shuda M, Chang Y, Moore P. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100.
9. Finn O. 2003. Cancer vaccines: Between the idea and the reality. Nat Rev Immunol 3:630-641.
10. Gaynor A, Nissen M, Whiley D, Mackay I, Lambert S, Wu G, Brennan D, Storch G, Sloots T, Wang D. 2007. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 3:e64.
11. Hadden JW. 2003. Immunodeficiency and cancer: Prospects for correction. Int Immunopharmacol 3:1061-1071.
12. Hobeika A, Morse M, Osada T, Ghanayem M, Niedzwiecki D, Barrier R, Lyerly H, Clay T. 2005. Enumerating antigen-specific T-cell responses in peripheral blood: A comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis. J Immunother 28:63-72.
13. Jasani B, Cristaudo A, Emri SA, Gazdar AF, Gibbs A, Krynska B, Miller C, Mutti L, Radu C, Tognon M, Procopio A. 2001a. Association of SV40 with human tumours. Semin Cancer Biol 11:49-61.
14. Jasani B, Jones CJ, Radu C, Wynford-Thomas D, Navabi H, Mason M, Adams M, Gibbs A. 2001b. Simian virus 40 detection in human mesothelioma: Reliability and significance of the available molecular evidence. Front Biosci 6:E12-E22.
15. Jasani B, Coleman S, Butchart E, Evans E, Adams M, Mason M, Gibbs A, Tabi Z. 2005. Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesothelioma. Vaccine 23:2399-2402.
16. Jin M, Sawa H, Suzuki T, Shimizu K, Makino Y, Tanaka S, Nojima T, Fujioka Y, Asamoto M, Suko N, Fujita M, Nagashima K. 2004. Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan. J Med Virol 74:668-676.
17. Klein G, Powers A, Croce C. 2002. Association of SV40 with human tumors. Oncogene 21:1141-1149.
18. Kroczynska B, Cutrone R, Bocchetta M, Yang H, Elmishad A, Vacek P, Ramos-Nino M, Mossman B, Pass H, Carbone M. 2006. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci USA 103:14128-14133.
19. Krymskaya L, Sharma M, Martinez J, Haq W, Huang E, Limaye A, Diamond D, Lacey S. 2005. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 79:11170-11178.
20. Lednicky J, Butel J. 1999. Polyomaviruses and human tumors: A brief review of current concepts and interpretations. Front Biosci 4:D153-D164.
21. Lemoine N, Mayall E, Jones T, Sheer D, McDermid S, Kendall-Taylor P, Wynford-Thomas D. 1989. Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br J Cancer 60:897-903.
22. Li J, Melenhorst J, Hensel N, Rezvani K, Sconocchia G, Kilical Y, Hou J, Curfman B, Major E, Barrett A. 2006. T-cell responses to peptide fragments of the BK virus T antigen: Implications for cross-reactivity of immune response to JC virus. J Gen Virol 87:2951-2960.
23. Lundstig A, Dillner J. 2006. Serological diagnosis of human polyomavirus infection. Adv Exp Med Biol 577:96-101.
24. McNees A, White Z, Zanwar P, Vilchez R, Butel J. 2005. Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J Clin Virol 34:52-62.
25. Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z. 2002. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99:2913-2921.
26. Pantaleo G, Harari A. 2006. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol 6:417-423.
27. Pietruska J, Kane A. 2007. SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells. Cancer Res 67:3637-3645.
28. Pipas JM. 1992. Common and unique features of T antigens encoded by the polyomavirus group. J Virol 66:3979-3985.
29. Robinson C, van Bruggen I, Segal A, Dunham M, Sherwood A, Koentgen F, Robinson B, Lake R. 2006. A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: Malignant transformation is dose dependent. Cancer Res 66:10786-10794.
30. Sharma M, Zhou W, Martinez J, Krymskaya L, Srivastava T, Haq W, Diamond D, Lacey S. 2006. Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals. Virology 350:128-136.
31. Shivapurkar N, Wiethege T, Wistuba II, Salomon E, Milchgrub S, Muller KM, Churg A, Pass H, Gazdar AF. 1999. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 76:181-188.
32. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. 2003. Seroepidemiology of the human polyomaviruses. J Gen Virol 84:1499-1504.
33. Tsai B, Gilbert J, Stehle T, Lencer W, Benjamin T, Rapoport T. 2003. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J 22:4346-4355.
34. Velders MP, Macedo MF, Provenzano M, Elmishad AG, Holzhutter HG, Carbone M, Kast WM. 2001. Human T cell responses to endogenously presented HLA-A*0201 restricted peptides of Simian virus 40 large T antigen. J Cell Biochem 82:155-162.
35. Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, Finch CJ, Butel JS. 2002. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 359:817-823.